Updated COVID-19 vaccines are already showing up on some pharmacy and health provider shelves. But a key program that paid for the vaccines when people lacked coverage is out of money. So those who are under-insured or uninsured could pay up to $200 for the booster.
The good news is, the risk of developing Long COVID has dropped significantly since the start of the pandemic—and, according to a new study, we have COVID-19 vaccines to thank for much of this decline. The bad news is, the risk of developing this post-acute infection syndrome remains substantial.
A new study in the Journal of Public Health suggests that it is more effective to emphasize the harms that come from not getting vaccinated rather than emphasizing the benefits of vaccination at the individual or community level.
“One of the challenges of today is just that people aren’t going to get vaccinated,” said Michael Osterholm, an epidemiologist and director of the University of Minnesota’s Center for Infectious Disease Research and Policy. “Most people are confused. They don’t really understand what’s happening or what the risk to them is,” when it comes to Covid.
:max_bytes(150000):strip_icc()/VWH-GettyImages-1585070896-13a09df8967842c2afdb22153b1d31fa.jpg)
